Cancer mortality trend analysis in Italy, 1970-2007

European Journal of Cancer Prevention

Volumn 20, Issue 5, 2011, Pages 364-374

  Arfè, Andrea ^a   Malvezzi, Matteo ^a,b   Bertuccio, Paola ^a   Decarli, Adriano ^b,c   La Vecchia, Carlo ^a,b   Negri, Eva ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

cancer; epidemiology; Italy; mortality; trends

Indexed keywords

ALCOHOL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BILE DUCT CANCER; BLADDER CANCER; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER MORTALITY; COLORECTAL CANCER; FEMALE; GALLBLADDER CANCER; HODGKIN DISEASE; HUMAN; INTESTINE CANCER; ITALY; KIDNEY CANCER; LARYNX CANCER; LEUKEMIA; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PANCREAS CANCER; PHARYNX CANCER; PLEURA CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; SOFT TISSUE SARCOMA; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; TOBACCO; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ITALY; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; SEX DISTRIBUTION; TIME FACTORS; YOUNG ADULT;

EID: 80051788069     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328345f99e     Document Type: Article

References (67)

1. Anderson RN, Rosenberg HM (2003). Disease classification: measuring the effect of the Tenth Revision of the International Classification of Diseases on cause-of-death data in the United States. Stat Med 22:1551-1570. (Pubitemid 36575601)
2. Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, et al. (2009). Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360:1310-1319.
3. Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Hery C, et al. (2010). Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 341:c3620.
4. Bill-Axelson A, Holmberg L, Ruutu M, Haggman M, Andersson SO, Bratell S, et al. (2005). Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 352:1977-1984. (Pubitemid 40638368)
5. Boffetta P, Stayner L (2006). Pleural and peritoneal neoplasms. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press. pp. 659-673.
6. Boffetta P, La Vecchia C (2009). Neoplasms. In: Detels R, Beaglehole R, Lansang MA, Gulliford M, editors. The practice of public health. Oxford Textbook of Public Health. Vol 3, 5th ed. New York: Oxford University Press. pp. 997-1020.
7. Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C (2005). Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol 16:489-511. (Pubitemid 40458329)
8. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C (2007). Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 46:827-839. (Pubitemid 46529045)
9. Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C (2008a). Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 48:137-145. (Pubitemid 351980469)
10. Bosetti C, Levi F, Ferlay J, Garavello W, Lucchini F, Bertuccio P, et al. (2008b). Trends in oesophageal cancer incidence and mortality in Europe. Int J Cancer 122:1118-1129. (Pubitemid 351214012)
11. Bosetti C, Levi F, Ferlay J, Lucchini F, Negri E, La Vecchia C (2008c). Incidence and mortality from non-Hodgkin lymphoma in Europe: the end of an epidemic? Int J Cancer 123:1917-1923.
12. Bosetti C, Bravi F, Negri E, La Vecchia C (2009a). Oral contraceptives and colorectal cancer risk: a systematic review and meta-analysis. Hum Reprod Update 15:489-498.
13. Bosetti C, Levi F, Ferlay J, Lucchini F, Negri E, La Vecchia C (2009b). The recent decline in mortality from Hodgkin lymphomas in central and eastern Europe. Ann Oncol 20:767-774.
14. Boyle P, Brawley OW (2009). Prostate cancer: current evidence weighs against population screening. CA Cancer J Clin 59:220-224.
15. Boyle P, Autier P, Bartelink H, Baselga J, Boffetta P, Burn J, et al. (2003). European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 14:973-1005. (Pubitemid 36950159)
16. Brennan P, Van der Hel O, Moore LE, Zaridze D, Matveev V, Holcatova I, et al. (2008). Tobacco smoking, body mass index, hypertension, and kidney cancer risk in central and eastern Europe. Br J Cancer 99:1912-1915.
17. Brown LM (2000). Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22:283-297. (Pubitemid 32116099)
18. Brown P, Hunger SP, Smith FO, Carroll WL, Reaman GH (2009). Novel targeted drug therapies for the treatment of childhood acute leukemia. Expert Rev Hematol 2:145.
19. Cirera Suarez L, Rodriguez Barranco M, Madrigal de Torres E, Carrillo Prieto J, Hasiak Santo A, Augusto Becker R, et al. (2006). Correspondences from 10th to 9th Revision of the International Classification of Diseases in the causes of death lists of the National Institute of Statistics and the Regional Health Authority of Murcia in Spain. Rev Esp Salud Publica 80:157-175. (Pubitemid 44379896)
20. Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, et al. (2008). Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst 100:388-398. (Pubitemid 351480516)
21. Doll R, Peto R (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 66:1191-1308. (Pubitemid 11063920)
22. Doll R, Peto R (1985). The effects on health of exposure to asbestos. Health & Safety Commission. London: Her Majesty's Stationery Office.
23. Doll R, Smith PG, Waterhouse JAH, Muir CS, Shanmugaratnam K, Powell J, et al. (1982). Comparison between registries: age-standardized rates. In: Waterhouse JAH, Muir CS, Shanmugaratnam K, Powell J, Peacham D, Whelan S, editors. Cancer incidence in five continents. Lyon: IARC Press. pp. 671-675.
24. Doll R, Peto R, Boreham J, Sutherland I (2005). Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 92:426-429. (Pubitemid 40395521)
25. Ferlay J, Randi G, Bosetti C, Levi F, Negri E, Boyle P, et al. (2008). Declining mortality from bladder cancer in Europe. BJU Int 101:11-19. (Pubitemid 350233570)
26. Frova L, Marchetti S, Pace M (2005). Automatic classification of causes of death in Italy: methodological aspects and ICD X implementation. Rome: Istituto Nazionale di Statistica. Available at: http://www.istat.it/dati/ catalogo/20050118-00/nuova-codautomtesto.pdf. [Accessed 12 January 2009]
27. Gallus S, Colombo P, Scarpino V, Zuccaro P, Negri E, Apolone G, et al. (2006). Overweight and obesity in Italian adults 2004, and an overview of trends since 1983. Eur J Clin Nutr 60:1174-1179. (Pubitemid 44489965)
28. Gallus S, Negri E, Boffetta P, McLaughlin JK, Bosetti C, La Vecchia C (2008). European studies on long-term exposure to ambient particulate matter and lung cancer. Eur J Cancer Prev 17:191-194. (Pubitemid 351549657)
29. Garattini S, La Vecchia C (2001). Perspectives in cancer chemotherapy. Eur J Cancer 37 (Suppl 8): S128-S147.
30. Griffiths C, Brock A, Rooney C (2004). The impact of introducing ICD-10 on trends in mortality from circulatory diseases in England and Wales. Health Stat Q 22:14-20.
31. Grimbizis GF, Tarlatzis BC (2010). The use of hormonal contraception and its protective role against endometrial and ovarian cancer. Best Pract Res Clin Obstet Gynaecol 24:29-38.
32. Gruber SB, Armstrong BK (2006). In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press. pp. 1196-1229.
33. Hunt JD, Van der Hel OL, McMillan GP, Boffetta P, Brennan P (2005). Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer 114:101-108. (Pubitemid 40194314)
34. IARC (2003). Fruit and vegetables. In: Vainio H, Bianchini F, editors. IARC handbooks of cancer prevention. Vol 8. Lyon: IARC Press. pp. 1-376.
35. IARC (2004). Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans. Vol 83. Lyon: IARC Press.
36. Karim-Kos HE, De Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW (2008). Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44:1345-1389.
37. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000). Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335-351. (Pubitemid 30070608)
38. La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E (1997). Epidemiology and prevention of oral cancer. Oral Oncol 33:302-312. (Pubitemid 28129230)
39. La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, et al. (2010). Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 21:1323-1360.
40. Levi F, Lucchini F, Negri E, Barbui T, La Vecchia C (2000). Trends in mortality from leukemia in subsequent age groups. Leukemia 14:1980-1985.
41. Levi F, Lucchini F, Boyle P, Negri E, La Vecchia C (2003a). Testicular cancer mortality in Eastern Europe. Int J Cancer 105:574. (Pubitemid 36578566)
42. Levi F, Lucchini F, Negri E, La Vecchia C (2003b). Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas 27:139-142. (Pubitemid 36950725)
43. Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C (2004). Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer 110:155-169. (Pubitemid 38580385)
44. Levi F, Ferlay J, Galeone C, Lucchini F, Negri E, Boyle P, et al. (2008). The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int 101:949-958. (Pubitemid 351422561)
45. Malvezzi M, Bosetti C, Negri E, La Vecchia C (2008). Cancer mortality in Italy, 1970-2002. Tumori 94:640-657.
46. Malvezzi M, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Decarli A (2009). Cancer mortality in Italy, 2003. Tumori 95:655-664.
47. National Cancer Institute (2008). Joinpoint Regression Program, version 3.1. Available at: http://srab.cancer.gov/joinpoint. [Accessed 21 April 2008]
48. Niitsu N (2010). Current treatment strategy of diffuse large B-cell lymphomas. Int J Hematol 92:231-237.
49. Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E (2004). The mesothelioma epidemic in Western Europe: an update. Br J Cancer 90:1022-1024. (Pubitemid 38495822)
50. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006). Mechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol 3:327-340. (Pubitemid 43871794)
51. Pelucchi C, Tramacere I, Bertuccio P, Tavani A, Negri E, La Vecchia C (2009). Dietary intake of selected micronutrients and gastric cancer risk: an Italian case-control study. Ann Oncol 20:160-165.
52. Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S, et al. (2009). Epidemiology of biliary tract cancers: an update. Ann Oncol 20:146-159.
53. Raza SA, Clifford GM, Franceschi S (2007). Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 96:1127-1134. (Pubitemid 46608308)
54. Rennert G, Rennert HS, Pinchev M, Lavie O, Gruber SB (2009). Use of hormone replacement therapy and the risk of colorectal cancer. J Clin Oncol 27:4542-4547.
55. Ron E, Schneider A (2006). Thyroid cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. rd ed. New York: Oxford University Press. pp. 975-994.
56. Rougier P, Mitry E (2003). Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol 14 (Suppl 2): ii3-ii5. (Pubitemid 36874131)
57. Shaffer EA (2006). Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol 20:981-996. (Pubitemid 44793722)
58. Sharifi N, Gulley JL, Dahut WL (2005). Androgen deprivation therapy for prostate cancer. JAMA 294:238-244. (Pubitemid 41043794)
59. Shibata A, Personnet J (2006). Stomach cancer. In: Schottenfeld D, Fraumeni JF Jr, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press. pp. 659-673.
60. Stegmeier F, Warmuth M, Sellers WR, Dorsch M (2010). Targeted cancer therapies in the twenty-first century: lessons from imatinib. Clin Pharmacol Ther 87:543-552.
61. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Cogliano V (2006). Carcinogenicity of household solid fuel combustion and of high-temperature frying. Lancet Oncol 7:977-978.
62. Tramacere I, Gallus S, Zuccaro P, Colombo P, Rossi S, Boffetta P, et al. (2009). Socio-demographic variation in smoking habits: Italy, 2008. Prev Med 48:213-217.
63. Vercelli M, Bellu F (2004). Cancers of the male genital organs: prostate and testis. Epidemiol Prev 28:75-81. [Accessed July 2010].
64. World Health Organization (1992) International statistical classification of disease and related health problems. 10th revision. Geneva: World Health Organization.
65. World Health Organization (2010). Alcohol drinking. Health topics. Geneva: World Health Organization. Available at: http://www.who.int/topics/ alcohol-drinking/en. [Accessed July 2010]
66. World Health Organization Statistical Information System (2010). WHO mortality database. Geneva: World Health Organization. Available at: http://www.who. int/healthinfo/morttables/en/index.html. [Accessed 10 July 2010]
67. World Health Organization (2010). Alcohol drinking. Health topics. Geneva: World Health Organization. Available at: http://www.who.int/topics/ alcohol-drinking/en/. [Accessed 15 October 2010]